Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Friday 08 February, 2019

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 5287P
GlaxoSmithKline PLC
08 February 2019
 

GlaxoSmithKline plc (the 'Company')

Transaction notification

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr N Hirons

b)

Position/status

SVP, Global Ethics & Compliance

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

American Depositary Shares ('ADSs')

ISIN: US37733W1053

 

b)

Nature of the transaction

The exercise of options over 4,600 ADSs, granted on 17 February 2009 under the GlaxoSmithKline Share Option Plan.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

$33.4200

1,608 (Non-Qualified Stock Option)

$33.4200

2,992 (Incentive Stock Option)

 

d)

Aggregated information

 

Aggregated volume Price

 

 

 

 

4,600
$33.4200

e)

Date of the transaction

2019-02-07

f)

Place of the transaction

 

n/a

 

 

 

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr N Hirons

b)

Position/status

SVP, Global Ethics & Compliance

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

American Depositary Shares ('ADSs')

ISIN: US37733W1053

 

b)

Nature of the transaction

The sale of 4,600 ADSs, following the exercise of options granted on 17 February 2009 under the GlaxoSmithKline Share Option Plan.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

$41.0800

1,608 (Non-Qualified Stock Option)

$41.0800

2,992 (Incentive Stock Option)

 

d)

Aggregated information

 

Aggregated volume Price

 

 

 

 

4,600
$41.0800

e)

Date of the transaction

2019-02-07

f)

Place of the transaction

 

New York Stock Exchange (XNYS)

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHLVLFBKLFFBBL

a d v e r t i s e m e n t